In a Friday interview with CNBC's Jim Cramer, Recursion Pharmaceuticals CEO Chris Gibson discussed how his company is using artificial intelligence and machine learning to create new drugs. Recursion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback